Skip to main content
OpenTrials
Completed

NCT Number: NCT05353023

Intensive Care Unit Activity in France From the National Database Between 2013 and 2019

Using data from the French National Uniform Hospital Discharge Database (systematically collecting administrative and medical information related to all hospitalized patients in France for care reimbursement purposes), the present study retrospectively assesses the activity of the French Intensive Care Unit (ICU)(1,594,801 ICU admissions):

* In-ICU and in-hospital mortality rates * Length of stay in ICU and hospital * Mortality-associated factors during the study period. * Number of organ failures * Bed occupancy, * Regional variations in previous indicators

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Intensive care Unit CHU Nîmes

Nîmes, 30029, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All adults patients admitted in French ICU between January 1st, 2013, to December 31st, 2019

Treatment and study plan

Primary outcomes

  1. Evolution in mortality rate

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the mortality rate of ICU patients over the study period (2013-19)

  2. Evolution in organ failure rate

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the organ failure rate of ICU patients over the study period (2013-19)

  3. Evolution in ICU stay

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the ICU stay of ICU patients over the study period (2013-19)

  4. Evolution in SAPS (Simplified Acute Physiology Score) II score at admission

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the SAPS II score at admission of ICU patients over the study period (2013-19)

  5. Evolution in age at admission

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the age at admission of ICU patients over the study period (2013-19)

  6. Evolution in sex ratio

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the sex ratio of ICU patients over the study period (2013-19)

Secondary outcomes

  1. Proportion of patients admitted in ICU with at least 2 different organ failures

    Time frame: from January 1st, 2013, to December 31st, 2019

    evolution of the proportion of patients admitted in ICU with at least 2 different organ failures corresponding to the definition of ICU in France.

  2. - Proportion of patients admitted in ICU with a SAPS II score over 15 and with a specific ICU supportive therapy

    Time frame: from January 1st, 2013, to December 31st, 2019

    Evolution of the proportion of patients admitted in ICU with a SAPS II score over 15 and with a specific ICU supportive therapy leading to a reimbursement by the French national health insurance.

  3. Factors Associated with in-ICU mortality

    Time frame: from January 1st, 2013, to December 31st, 2019

    Effect of year-time on in-ICU mortality

  4. Regional variations

    Time frame: from January 1st, 2013, to December 31st, 2019

    Evolution and potential differences between French regions in admission level

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Official study title

Intensive Care Unit Activity in France From the National Database Between 2013 and 2019: More Critically Ill Patients, Shorter Stay and Lower Mortality Rate

Acronym: ICU_ACTIVITY

Important dates

Study start
2013
Primary completion
2023
Study completion
2023
First posted
Apr 29, 2022
Registry last updated
Dec 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.